Home Cart 0 Sign in  

[ CAS No. 133970-31-7 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 133970-31-7
Chemical Structure| 133970-31-7
Structure of 133970-31-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 133970-31-7 ]

Related Doc. of [ 133970-31-7 ]

Alternatived Products of [ 133970-31-7 ]

Product Details of [ 133970-31-7 ]

CAS No. :133970-31-7 MDL No. :MFCD00065664
Formula : C29H29ClN2O6 Boiling Point : -
Linear Structure Formula :- InChI Key :VUEYAXRHPZGZOL-SANMLTNESA-N
M.W :537.00 g/mol Pubchem ID :45073227
Synonyms :

Safety of [ 133970-31-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 133970-31-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 133970-31-7 ]

[ 133970-31-7 ] Synthesis Path-Downstream   1~10

  • 1
  • [ 133970-31-7 ]
  • [ 105047-45-8 ]
YieldReaction ConditionsOperation in experiment
83.6% With trifluorormethanesulfonic acid; methyl-phenyl-thioether; trifluoroacetic acid at 4℃; for 1h;
  • 2
  • Fmoc-Leu-preloaded Wang resin, deprotected [ No CAS ]
  • [ 35661-40-6 ]
  • [ 86123-10-6 ]
  • [ 103478-58-6 ]
  • Fmoc-Lys(ClZ)-OH [ No CAS ]
  • NH2-Phe-D-Phe-Lys(2-Cl-Z)-N-Me-Val-Leu-OH [ No CAS ]
  • 3
  • [ 35661-60-0 ]
  • [ 103-40-2 ]
  • [ 71989-33-8 ]
  • [ 116611-64-4 ]
  • Fmoc-Lys(ClZ)-OH [ No CAS ]
  • BnO-succinyl-His-Ser-Ser-Lys(2-Cl-Z)-Leu-OH [ No CAS ]
YieldReaction ConditionsOperation in experiment
459 mg General procedure: All of the peptides were synthesized by Merrifield solid-phase peptide synthesis protocols using a double-coupling protocol on a bubbler peptide synthesizer. The resins for the peptide assembly were 2-methoxy-4-alkoxybenzyl alcohol (SASRIN, 200-400 mesh) resin, purchased from Bachem (Torrance, CA), or 4-hydroxymethylphenoxy (WANG-type HMP) resin, purchased from Advanced Chemtech (Louisville, KY). Nalpha-Fmoc-protected amino acids of the l-configuration and reagents were purchased from Advanced Chemtech. Side-chain protection was Ser(But) and Lys(Cl-Z). The capping group was introduced via monobenzyl succinate or monobenzyl glutarate. C-terminal amino acid was loaded using DMAP/DIC protocol for SASRIN resin, and HOBt/DMAP/DIC protocol for WANG resin, and threefold excess of activated protected amino acid was used for each coupling and recoupling, using NMP as solvent. Following completion of the assembly on the resin support, the N-terminal Fmoc group was removed via the standard 25% piperidine/NMP protocol, followed by washing 5 times with NMP and introduction of N-terminal capping group. Deprotection and removal of the peptide from the resin support were effected using 90% TFA in CH2Cl2 for both SASRIN and WANG resin. The benzyl esters of the capping groups were not affected under these conditions. After removal of solvents under reduced pressure, the peptides were purified by preparative HPLC on a reverse-phase radial compression C18 column (Waters, 15mum, 100A, 5×30cm). A step gradient was generated from 1L each of successively increasing concentration of mobile phase (solvent A, 0.1% TFA/H2O; solvent B, 0.1% TFA/CH3CN). A flow rate of 9mL/min was used to elute the peptide. Detection was performed by monitoring the UV absorbance at 220nm. Homogeneous product fractions (>98% pure) were pooled and freeze-dried. The homogeneity of the peptides was demonstrated by analytical reverse phase HPLC using a C18 column. Identities were confirmed by mass spectral analysis.
  • 4
  • [ 35661-60-0 ]
  • [ 103-40-2 ]
  • [ 71989-33-8 ]
  • [ 133970-31-7 ]
  • [ 1486479-05-3 ]
YieldReaction ConditionsOperation in experiment
538 mg Stage #1: Fmoc-Leu-OH With dmap; diisopropyl-carbodiimide In 1-methyl-pyrrolidin-2-one Automated synthesizer; Stage #2: With piperidine In 1-methyl-pyrrolidin-2-one Automated synthesizer; Stage #3: succinic acid monobenzyl ester; Fmoc-Ser(tBu)-OH; Fmoc-Lys(ClZ)-OH Further stages; 6.1.10 General methods for peptide synthesis General procedure: All of the peptides were synthesized by Merrifield solid-phase peptide synthesis protocols using a double-coupling protocol on a bubbler peptide synthesizer. The resins for the peptide assembly were 2-methoxy-4-alkoxybenzyl alcohol (SASRIN, 200-400 mesh) resin, purchased from Bachem (Torrance, CA), or 4-hydroxymethylphenoxy (WANG-type HMP) resin, purchased from Advanced Chemtech (Louisville, KY). Nα-Fmoc-protected amino acids of the l-configuration and reagents were purchased from Advanced Chemtech. Side-chain protection was Ser(But) and Lys(Cl-Z). The capping group was introduced via monobenzyl succinate or monobenzyl glutarate. C-terminal amino acid was loaded using DMAP/DIC protocol for SASRIN resin, and HOBt/DMAP/DIC protocol for WANG resin, and threefold excess of activated protected amino acid was used for each coupling and recoupling, using NMP as solvent. Following completion of the assembly on the resin support, the N-terminal Fmoc group was removed via the standard 25% piperidine/NMP protocol, followed by washing 5 times with NMP and introduction of N-terminal capping group. Deprotection and removal of the peptide from the resin support were effected using 90% TFA in CH2Cl2 for both SASRIN and WANG resin. The benzyl esters of the capping groups were not affected under these conditions. After removal of solvents under reduced pressure, the peptides were purified by preparative HPLC on a reverse-phase radial compression C18 column (Waters, 15μm, 100Å, 5×30cm). A step gradient was generated from 1L each of successively increasing concentration of mobile phase (solvent A, 0.1% TFA/H2O; solvent B, 0.1% TFA/CH3CN). A flow rate of 9mL/min was used to elute the peptide. Detection was performed by monitoring the UV absorbance at 220nm. Homogeneous product fractions (>98% pure) were pooled and freeze-dried. The homogeneity of the peptides was demonstrated by analytical reverse phase HPLC using a C18 column. Identities were confirmed by mass spectral analysis.
  • 5
  • [ 133970-31-7 ]
  • [ 1204431-11-7 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1.1: diisopropyl-carbodiimide; benzotriazol-1-ol / N,N-dimethyl-formamide / 1 h 1.2: 2.5 h / 25 °C 2.1: pyridine hydrochloride 2.2: 24 h 3.1: hydrogen fluoride
  • 6
  • [ 133970-31-7 ]
  • [ 1675230-39-3 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1.1: diisopropyl-carbodiimide; benzotriazol-1-ol / N,N-dimethyl-formamide / 1 h 1.2: 2.5 h / 25 °C 2.1: pyridine hydrochloride 2.2: 24 h
  • 7
  • [ 133970-31-7 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: diisopropyl-carbodiimide; benzotriazol-1-ol / N,N-dimethyl-formamide / 1 h 1.2: 2.5 h / 25 °C 2.1: pyridine hydrochloride 2.2: 24 h 3.1: hydrogen fluoride 4.1: Dulbecco's modified Eagle's medium GlutaMAX-I / 24 h / 37 °C
  • 8
  • [ 133970-31-7 ]
  • [ CAS Unavailable ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: diisopropyl-carbodiimide; benzotriazol-1-ol / N,N-dimethyl-formamide / 1 h 1.2: 2.5 h / 25 °C 2.1: pyridine hydrochloride 2.2: 24 h 3.1: hydrogen fluoride 4.1: Dulbecco's modified Eagle's medium GlutaMAX-I / 48 h / 37 °C
  • 9
  • [ CAS Unavailable ]
  • [ 76-05-1 ]
  • [ 133970-31-7 ]
  • [ 1675230-40-6 ]
YieldReaction ConditionsOperation in experiment
Stage #1: C17H30N9O7Pol; Fmoc-Lys(ClZ)-OH With benzotriazol-1-ol; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 1h; Stage #2: trifluoroacetic acid With chlorotriisopropylsilane In water at 25℃; for 2.5h;
  • 10
  • 2-chlorotrityl chloride polystyrene resin [ No CAS ]
  • [ 35661-40-6 ]
  • [ 115186-31-7 ]
  • FMoc-L-2,6-dimethyltyrosine [ No CAS ]
  • Fmoc-Lys(ClZ)-OH [ No CAS ]
  • C64H73Cl2N6O10Pol [ No CAS ]
Historical Records

Related Functional Groups of
[ 133970-31-7 ]

Amino Acid Derivatives

Chemical Structure| 198560-44-0

[ 198560-44-0 ]

Fmoc-Phe(3-Cl)-OH

Similarity: 0.93

Chemical Structure| 177966-58-4

[ 177966-58-4 ]

Fmoc-D-Phe(3,4-DiCl)-OH

Similarity: 0.92

Chemical Structure| 177966-59-5

[ 177966-59-5 ]

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid

Similarity: 0.92

Chemical Structure| 142994-19-2

[ 142994-19-2 ]

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-chlorophenyl)propanoic acid

Similarity: 0.92

Chemical Structure| 478183-58-3

[ 478183-58-3 ]

Fmoc-Tyr(3-Cl)-OH

Similarity: 0.88